Navigation Links
FDA Grants Orphan Drug Designation to Omeros' OMS824 for Huntington's Disease
Date:9/30/2013

elerate the development of OMS824 and recognizes the important work conducted at Omeros," stated Gregory A. Demopulos, M.D., chairman and chief executive officer of Omeros. "The manifestations of Huntington's are devastating to both Huntington's patients and their families, yet there is only one currently approved therapeutic and it is focused on a single symptom of the disease. OMS824 holds the promise of expanding treatment across the constellation of debilitating effects of Huntington's. We look forward to working with the FDA to advance the clinical evaluation of OMS824 in patients suffering from Huntington's disease and plan to initiate enrollment in a Phase 2 trial later this year."

About Omeros' PDE10 Program
PDE10 is an enzyme that is expressed in areas of the brain linked to diseases that affect cognition and psychomotor functions, including Huntington's disease and schizophrenia. Huntington's disease is a hereditary neurodegenerative disorder that leads to movement, cognition, and behavioral abnormalities and premature death. Schizophrenia is a group of severe brain disorders characterized by an abnormal interpretation of reality, which can manifest as delusions, hallucinations, and/or disordered thinking and behavior. Cognitive dysfunction is responsible for substantial disability in both of these diseases and is not meaningfully improved by current medications. Omeros' proprietary compound OMS824 inhibits PDE10 and is being developed for the treatment of cognitive disorders. In addition to potential benefits on cognition, OMS824 could also improve the motor and psychiatric abnormalities in Huntington's disease as well as the positive (e.g., hallucinations) and negative (e.g., flat affect) symptoms of schizophrenia.

About Omeros Corporation
Omeros is a clinical-stage biopharmaceutical company committed to discovering, developing and commercializing small-molecule and protein therapeutics targeting inflam
'/>"/>

SOURCE Omeros Corporation
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Nektar Announces that FDA Grants Fast Track Designation to NKTR-181, a New Oral Opioid Analgesic Molecule, for the Treatment of Moderate to Severe Chronic Pain
2. Community Foundation Announces $2.6 Million In Grants From Centinela Medical Funds
3. U.S. FDA Grants Priority Review to the New Drug Application for Bayers Regorafenib to Treat Patients with Metastatic Colorectal Cancer
4. European Commission Grants Orphan Medicinal Product Designation for Emmaus Medicals Sickle Cell Treatment
5. FDA Grants Orphan Drug Designation To GeNO LLC For Use Of Inhaled Nitric Oxide In Treatment Of Persistant Pulmonary Hypertension Of The Newborn (PPHN)
6. Rep. Fattah Announces More Than $10.7 Million in Grants for Neuroscience, Scientific and Medical Research in Philadelphia
7. U.S. FDA Grants Priority Review to Bedaquiline (TMC207) for Multi-Drug Resistant Tuberculosis Treatment
8. Neuralstem Grants First Licenses For CNS Therapy Surgical Devices
9. EMA Grants Orphan Designation to Edison Pharmaceuticals for EPI-743 for Treatment of Leigh Syndrome
10. As Global Telemedicine Market Reaches $2.5 Billion, Industry Leaders Gather in San Diego to Discuss Grants, Funding, Vendor Selection, Credentialing, and More
11. Nektar Announces that FDA Grants Fast Track Designation to Etirinotecan Pegol (NKTR-102) for the Treatment of Metastatic Breast Cancer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/31/2015)... DUBLIN , Mar. 30, 2015 Research ... announced the addition of the "Eurpoean Automatic ... Fully-Automated), End-User (Pre-Hospitals, Public Access Market, Hospitals, Alternate ... report to their offering. The European ... grow at a CAGR of 10.9% from 2014 ...
(Date:3/31/2015)...  The efficacy of continuous UV-C disinfection robots versus ... study 1 of ultraviolet (UV) light disinfection systems ... Curtis Donskey , M.D.  The study tested a continuous ... of time from the same point in the room ... surprisingly low pathogen kill rates for the pulsed xenon ...
(Date:3/31/2015)... 2015 RnRMarketResearch.com adds "Pemphigus ... report of 68 pages with latest updates, data ... The report "Pemphigus - Pipeline Review, H1 2015" ... development for Pemphigus , complete with comparative analysis ... mechanism of action (MoA), route of administration (RoA) ...
Breaking Medicine Technology:Eurpoean Automatic External Defibrillators (Semi-Automated, Fully-Automated) Market 2015-2019 - Pre-Hospitals, Public Access Market, Hospitals, Alternate Care Market, Home Analysis 2Eurpoean Automatic External Defibrillators (Semi-Automated, Fully-Automated) Market 2015-2019 - Pre-Hospitals, Public Access Market, Hospitals, Alternate Care Market, Home Analysis 3VA Funded Study Validates Continuous UV-C Technology For Pathogen Reduction 2VA Funded Study Validates Continuous UV-C Technology For Pathogen Reduction 3VA Funded Study Validates Continuous UV-C Technology For Pathogen Reduction 4Pemphigus Therapeutic Development and Pipeline Review H1 2015 2Pemphigus Therapeutic Development and Pipeline Review H1 2015 3Pemphigus Therapeutic Development and Pipeline Review H1 2015 4
... Saudi Arabia, Nov. 2, 2010 The Saudi Arabian ... has signed an agreement with Varian Medical Systems and ... magnetic resonance-guided radiation therapy (MRgRT™). Under the ... solution that combines IMRIS, unique movable magnetic resonance imaging ...
... Quarter 2010 Results and Host Conference... -- POINT RICHMOND, Calif., Nov. 2, 2010 ... ... if (typeof(lpUnit)==,undefined,) var lpUnit=,PRN,; --> ... var shortURL = ""; BitlyCB.alertResponse = function(data) { var s = ,; var first_result; // Results ...
Cached Medicine Technology:Saudi Arabia's King Abdullah International Research Center Signs With Varian Medical Systems and IMRIS for Future Technology for Use in Radiotherapy 2Saudi Arabia's King Abdullah International Research Center Signs With Varian Medical Systems and IMRIS for Future Technology for Use in Radiotherapy 3Saudi Arabia's King Abdullah International Research Center Signs With Varian Medical Systems and IMRIS for Future Technology for Use in Radiotherapy 4Transcept Pharmaceuticals to Report Third Quarter 2010 Results and Host Conference Call on November 11, 2010 2Transcept Pharmaceuticals to Report Third Quarter 2010 Results and Host Conference Call on November 11, 2010 3Transcept Pharmaceuticals to Report Third Quarter 2010 Results and Host Conference Call on November 11, 2010 4Transcept Pharmaceuticals to Report Third Quarter 2010 Results and Host Conference Call on November 11, 2010 5Transcept Pharmaceuticals to Report Third Quarter 2010 Results and Host Conference Call on November 11, 2010 6Transcept Pharmaceuticals to Report Third Quarter 2010 Results and Host Conference Call on November 11, 2010 7Transcept Pharmaceuticals to Report Third Quarter 2010 Results and Host Conference Call on November 11, 2010 8Transcept Pharmaceuticals to Report Third Quarter 2010 Results and Host Conference Call on November 11, 2010 9
(Date:3/31/2015)... 31, 2015 Students, teachers, and the ... education in a drastically different way as current and ... and training content is being delivered and received. , ... technology in an unprecedented way with education becoming individualized, ... co-founder and CEO, My Mobile University , This ...
(Date:3/31/2015)... 2015 The Walk a Mile Project, as ... , just kicked off their 3rd research sequence. The ... “ Substantial Equivalence was and is a massive component ... Director at Change The World Films. “We started our ... GMOs even entered our food supply, just to get a ...
(Date:3/31/2015)... March 31, 2015 Dr. ... by the American Board of Dermatology and fellowship ... research training at the National Cancer Institute of ... his internship in internal medicine at the Emory ... Pennsylvania in Philadelphia. Dr. Li pursued further training ...
(Date:3/31/2015)... NJ (PRWEB) March 31, 2015 Dr. Russell ... for Advanced Reconstruction. He was recently quoted in an ... caused by lymphatic issues, causing fluid retention and tissue swelling. ... procedure to relieve and / or improve lymphedema symptoms. ... improve or alleviate the symptoms of lymphedema. The goal ...
(Date:3/31/2015)... Mirada, CA (PRWEB) March 31, 2015 ... treating hip injuries at all of their clinics. Specialties ... or disorders. , For athletes with hip injuries, ... ready to assess and treat the symptoms and underlying ... to provide minimally-invasive care and prevent future damage, while ...
Breaking Medicine News(10 mins):Health News:LTT Global Communications Launches First Asia Holistic Online Learning Platform 2Health News:LTT Global Communications Launches First Asia Holistic Online Learning Platform 3Health News:The Walk a Mile Project Launches New Research Sequence on Substantial Equivalence of GMOs 2Health News:Dr. Andrew Li of Warren Skin Care Center Is Celebrating 3 Years Recognized as an "NJ Top Doc" 2Health News:The Physicians at Plastic Surgery Center Each Have Something to Celebrate This March 2Health News:The Physicians at Plastic Surgery Center Each Have Something to Celebrate This March 3Health News:The Physicians at Plastic Surgery Center Each Have Something to Celebrate This March 4Health News:Healthpointe Now Treating Hip Dislocations, Hip Fractures, Hip Bursitis, and Hip Strains at Locations in Southern California 2
... FRIDAY, April 6 (HealthDay News) -- Anxiety improves a ... a new study. Smell is essential to animals ... also trigger powerful emotional responses in humans, the study ... Li of the University of Wisconsin-Madison exposed 14 young ...
... the University of California, San Diego and Veterans Affairs ... pressure may increase the risk of cerebrovascular disease (CVD) ... study has been published in the early online edition ... of the June 5 print publication. The findings ...
... Calif. An invasive heart test used routinely to ... patients who recently underwent similar, more effective tests, according ... of Medicine. "This adds both risk to the ... the study Ronald Witteles, MD, assistant professor of cardiovascular ...
... -- Children with autism who were born either prematurely or ... with autism who were born on time, according to a ... to inflict self-injury, researchers found. Although the reasons their ... may have something to do with what caused the children ...
... clock controls many aspects of human behavior and physiology, ... rhythms leads to increased incidence of many diseases, including ... has its own internal timing mechanism, which is controlled ... One of these proteins, called Rev-erb alpha, was thought ...
... HealthDay Reporter , THURSDAY, April 5 (HealthDay News) -- ... antibiotics may be just as good as having the ... studies involving hundreds of patients to determine that treatment ... which has been the so-called "gold standard" of care ...
Cached Medicine News:Health News:Pulse pressure elevation could presage cerebrovascular disease in Alzheimer's patients 2Health News:Invasive heart test being dramatically overused, Stanford study shows 2Health News:Invasive heart test being dramatically overused, Stanford study shows 3Health News:Pregnancy Length May Influence Severity of Autism 2Health News:Coordinating the circadian clock: Molecular pair controls time-keeping and fat metabolism 2Health News:Study Finds Antibiotics Best for Appendicitis 2Health News:Study Finds Antibiotics Best for Appendicitis 3
Designed for the effective positioning of patients during spinal surgery, the frame gives the surgeon a remarkably simple and versatile surgical tool....
High temperature loop tip cautery....
Low temp, micro fine tip, patented Aaron RAM cauteries....
6 mm, 45 degree upwards, detachable....
Medicine Products: